Effects of Two Doses of Anti-T Lymphocyte Globulin-Fresenius Given after Full-match Sibling Stem Cell Transplantation in Acute Myeloblastic Leukemia Patients Who Underwent Myeloablative Fludarabine/Busulfan Conditioning
Conclusion Dose difference of rATG-F did not influence survival parameters; however, increasing the dose to 30 mg/kg seems to be effective for reducing cGVHD with an increase in infection rate requiring close monitoring of infections in AML patients who received myeloablative fludarabine/busulfan conditioning.
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Bone Graft | Cancer & Oncology | Chronic Leukemia | Hematology | Leukemia | Methotrexate | Restasis | Stem Cell Therapy | Stem Cells | Study | Toxicology | Transplants